Magna Labs provides software infrastructure to safely develop, test, and deploy precision science and medicine at scale. We believe the future of biotech and precision medicine -- everything from genetic home-testing to personalized tumor vaccines -- hinges on timely and accurate computation. In order to bring that future to life, scientific and computational R&D teams require rigorous testing, optimization, and adoption of modern software techniques. Magna's suite of products, focused on automation and analytics, enables research teams and companies of all sizes to comprehensively test and rapidly accelerate their scientific software development.
Location: United States, Virginia, Falls Church
Employees: 1-10
Founded date: 2020
Investors 1
| Date | Name | Website |
| - | Merck Digi... | mds.studio |
Mentions in press and media 2
| Date | Title | Description |
| 12.09.2024 | VIPC Awards Technology Commercialization Grant to Magna Labs to Accelerate Development of Groundbreaking No-Code QA Software for Precision Medicine | Magna Labs offers novel automation solution that validates and benchmarks bioinformatic and scientific software to rapidly turn data into actionable insights. It is critical to the future of precision science and medicine that we improve bo... |
| 19.12.2022 | Merck Digital Sciences Studio Announces the Launch of its First Cohort | NEWARK, N.J. (PRWEB) December 19, 2022 On Friday December 16, Merck (NYSE: MRK) today announced the launch of their first biopharmaceutical cohort through the Merck Digital Sciences Studio (MDSS), a collaboration between Merck, Microsoft fo... |